Parkinsonian patients report blunted subjective effects of methylphenidate

Experimental and Clinical Psychopharmacology

Volumn 6, Issue 1, 1998, Pages 54-63

  Persico, Antonio M ^a,b   Henningfield, Jack E ^a   Kuhar, Michael J ^a   Reich, Steven ^c   Uhl, George R ^a,c  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b Libero Istituto Universitario   (Italy)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMANTADINE; ANTIPARKINSON AGENT; BROMOCRIPTINE; CARBIDOPA PLUS LEVODOPA; METHYLPHENIDATE; PLACEBO; SELEGILINE; TRIHEXYPHENIDYL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DOSE RESPONSE; FEMALE; HUMAN; HUMAN EXPERIMENT; MALE; MOOD; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PARKINSON DISEASE; VERTIGO;

ADULT; AFFECT; AGED; DEPRESSIVE DISORDER; DOPAMINE UPTAKE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART RATE; HUMANS; MALE; METHYLPHENIDATE; MIDDLE AGED; PARKINSON DISEASE; REWARD;

EID: 13144266693     PISSN: 10641297     EISSN: None     Source Type: Journal    
DOI: 10.1037/1064-1297.6.1.54     Document Type: Article

References (49)

1. Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561-571.
2. Cantello, R., Aguggia, M., Gilli, M., Delsedime, M., Chiardo Cutin, I., Riccio, A., & Mutani, R. (1989). Major depression in Parkinson's disease and the mood response to intravenous methylphenidate: Possible role of the "hedonic" dopamine synapse. Journal of Neurology, Neurosurgery, and Psychiatry, 52, 724-731.
3. Cantello, R., Aguggia, M., Gilli, M., Delsedime, M., Riccio, A., Rainero, I., & Mutani, R. (1988). Analgesic action of methylphenidate on parkinsonian sensory symptoms. Archives of Neurology, 45, 973-976.
4. Chait, L. D., Uhlenhuth, E. H., & Johanson, C. E. (1987). Reinforcing and subjective effects of several anorectics in normal volunteers. Journal of Pharmacology and Experimental Therapeutics, 242, 777-783.
5. Cooper, J. R., Bloom, F. E., & Roth, R. H. (1991). The biochemical basis of neuropharmacology (6th ed., pp. 285-337). Oxford, England: Oxford University Press.
6. Costall, B., & Naylor, R. J. (1973). The involvement of dopaminergic systems with the stereotyped behavior patterns induced by methylphenidate. Journal of Pharmacy and Pharmacology, 26, 30-33.
7. Cummings, J. L. (1992). Depression and Parkinson's disease: A review. American Journal of Psychiatry, 149, 443-454.
8. D'Amato, R. J., Zweig, R. M., Whitehouse, P. J., Wenk, G. L., Singer, H. S., Mayeux, R., Price, D. L., & Snyder, S. H. (1987). Aminergic systems in Alzheimer's disease and Parkinson's disease. Annals of Neurology, 22, 229-236.
9. Dooneief, G., Mirabello, E., Bell, K., Marder, K., Stern, Y., & Mayeux, R. (1992). An estimate of the incidence of depression in idiopathic Parkinson's disease. Archives of Neurology, 49, 305-307.
10. Dupont, W. D., & Plummet, W. D., Jr. (1990). Power and sample size calculations - A review and computer program. Controlled Clinical Trials, 11, 116-128.
11. Ferris, R. M., Tang, F. L. M., & Maxwell, R. A. (1972). A comparison of the capacities of isomers of amphetamine, deoxypipradrol and methylphenidate to inhibit the uptake of tritiated catecholamines into rat cerebral cortex slices, synaptosomal preparations of rat cerebral cortex, hypothalamus and striatum and into adrenergic nerves of rabbit aorta. Journal of Pharmacology and Experimental Therapeutics, 181, 407-416.
12. Finnegan, K. T., Ricaurte, G., Seiden, L. S., & Schuster, C. R. (1982). Altered sensitivity to d-methylamphetamine, apomorphine, and haloperidol in rhesus monkeys depleted of caudate dopamine by repeated administration of d-methylamphetamine. Psychopharmacology, 77, 43-52.
13. Fischman, M. W., & Schuster, C. R. (1977). Long-term behavioral changes in the rhesus monkey after multiple daily injections of d-methylamphetamine. Journal of Pharmacology and Experimental Therapeutics, 201, 593-605.
14. Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). "Mini-mental state," a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189-198.
15. Fraser, H. F., Van Horn, G. D., Martin, W. R., Wolbach, A. B., & Isbell, H. (1961). Methods for evaluation of addiction liability. (A) "Attitude" of opiate addicts toward opiate-like drugs; (B) A short-term "direct" addiction test. Journal of Pharmacology and Experimental Therapeutics, 133, 371-387.
16. Gaspar, P., Berger, B., Favret, A., Vigny, A., & Henry, J.-P. (1989). Catecholamine innervation of the human cerebral cortex as revealed by comparative immunohistochemistry of tyrosine hydroxylase and dopamine beta hydroxylase. Journal of Comparative Neurology, 279, 249-271.
17. German, D. C., Manaye, K. F., White, C. L. III, Woodward, D. J., McIntire, D. D., Smith, W. K., Kalaria, R. N., & Mann, D. M. A. (1992). Disease-specific patterns of locus coeruleus cell loss. Annals of Neurology, 32, 667-676.
18. Geyer, M. A., Dawsey, W. J., & Mandell, A. J. (1975). Differential effects of caffeine, D-amphetamine and methylphenidate on individual raphe cell fluorescence: A microspectrofluorimetric demonstration. Brain Research, 85, 135-139.
19. Greenfield, J. G., & Bosanquet, F. D. (1953). The brain-stern lesions in parkinsonian. Journal of Neurology, Neurosurgery, and Psychiatry, 16, 213-226.
20. Halliday, G. M., & Tork, I. (1986). Comparative anatomy of the ventromedial mesencephalic tegmentum in the rat, cat, monkey and human. Journal of Comparative Neurology, 252, 423-445.
21. Heffner, T. G., & Seiden, L. S. (1979). The effect of depletion of brain dopamine by 6-hydroxydopamine on tolerance to the anorexic effect of d-amphetamine and fenfluramine in rats. Journal of Pharmacology and Experimental Therapeutics, 208, 134-143.
22. 3H]dopamine in rat brain tissue slices. Biochemical Pharmacology, 24, 847-852.
23. Heishman, S. J., & Henningfield, J. E. (1991). Discriminative stimulus and subjective effects of d-amphetamine, methylphenidate and diazepam in humans. Psychopharmacology, 103, 436-442.
24. Hirsch, E. C., Graybiel, A. M., & Agid, Y. (1988). Melanized dopaminergic neurons are differentially affected in Parkinson's disease. Nature, 334, 345-348.
25. Hoehn, M. M., & Yahr, M. D. (1967). Parkinsonism: Onset, progression and mortality. Neurology, 13, 427-442.
26. Hornykiewicz, O. (1988). Neurochemical pathology and the etiology of Parkinson's disease: Basic facts and hypothetical possibilities. Mount Sinai Journal of Medicine, 55, 11-20.
27. 3H]mazindol binding associated with neuronal dopamine and norepinephrine uptake sites. Molecular Pharmacology, 26, 35-44.
28. Javoy-Agid, F., Ruberg, M., Taquet, H., Bokobza, B., Agid, Y., & Gaspar, P. (1984). Biochemical neuropathology of Parkinson's disease. Advances in Neurology, 40, 189-198.
29. Jonsson, L. E., Anggard, E., & Gunne, L. M. (1971). Blockade of intravenous amphetamine euphoria in man. Clinical Pharmacology and Therapeutics, 12, 889-896.
30. Joyce, P. R., Donald, R. A., Nicholls, M. G., Livesey, J. H., & Abbott, R. M. (1986). Endocrine and behavioral responses to methylphenidate in normal subjects. Biological Psychiatry, 21, 1015-1023.
31. Koob, G. F., & Bloom, F. E. (1988). Cellular and molecular mechanisms of drug dependence. Science, 242, 715-723.
32. Kuhar, M. J., Ritz, M. C., & Boja, J. W. (1991). The dopamine hypothesis of the reinforcing properties of cocaine. Trends in Neurosciences, 14, 299-302.
33. Martin, W. R., Sloan, J. W., Sapira, J. D., & Jasinski, D. R. (1971). Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clinical Pharmacology and Therapeutics, 12, 245-258.
34. Maxwell, R. A., Plummer, A. J., Ross, S. D., & Daniel, A. I. (1958). Studies concerning the cardiovascular actions of the central nervous stimulant, methylphenidate. Journal of Pharmacology and Experimental Therapeutics, 123, 22-27.
35. McGeer, P. L., McGeer, E. G., & Suzuki, J. S. (1977). Aging and extrapyramidal function. Archives of Neurology, 34, 33-35.
36. McMillen, B. A. (1983). CNS stimulants: Two distinct mechanisms of action for amphetamine-like drugs. Trends in Pharmacological Sciences, 5, 429-432.
37. McNair, D. M., Lorr, M., & Droppleman, L. F. (1971). EITS Manual for Profile of Mood States. San Diego, CA: Education and Industrial Testing Service.
38. Patrick, K. S., Mueller, R. A., Gualtieri, T., & Breese, G. R. (1987). Pharmacokinetics and actions of methylphenidate. In H. Y. Meltzer (Ed.), Psychopharmacology - The third generation of progress (pp. 1387-1395). New York: Raven Press.
39. Reches, A., Wagner, H. R., Jackson-Lewis, V., Yablonskaya-Alter, E., & Fahn, S. (1984). Chronic levodopa or pergolide administration induces down-regulation of dopamine receptors in denervated striatum. Neurology, 34, 1208-1212.
40. Roberts, D. C. S., Corcoran, M. E., & Fibiger, H. C. (1977). On the role of ascending catecholamine systems in intravenous self-administration of cocaine. Pharmacology Biochemistry and Behavior, 6, 615-620.
41. Roberts, D. C. S., & Koob, G. F. (1982). Disruption of cocaine self-administration following 6-hydroxydopamine lesions of the ventral tegmental area in rats. Pharmacology Biochemistry and Behavior, 17, 901-904.
42. Robinson, T., & Berridge, K. C. (1993). The neural basis of drug craving: An incentive-sensitization theory of addiction. Brain Research Reviews, 18, 249-291.
43. Scheel-Kruger, J. (1971). Comparative study of various amphetamine analogues demonstrating different interactions with the metabolism of the catecholamines in the brain. European Journal of Pharmacology, 14, 47-59.
44. Smith, R. C., & Davies, J. M. (1977). Comparative effects of d-amphetamine, 1-amphetamine, and methylphenidate on mood in man. Psychopharmacology, 53, 1-12.
45. Torrack, R. M., & Morris, J. C. (1988). The association of ventral tegmental area histopathology with adult dementia. Archives of Neurology, 45, 497-501.
46. Uhl, G. R., Hedreen, J. C., & Price, D. L. (1985). Parkinson's disease: Loss of neurons from the ventral tegmental area contralateral to therapeutic surgical lesions. Neurology, 35, 1215-1218.
47. Walsh, S. L., & Wagner, G. C. (1992). Motor impairments after methamphetamine-induced neurotoxicity in the rat. Journal of Pharmacology and Experimental Therapeutics, 263, 617-626.
48. Wise, R. A., & Bozarth, M. A. (1987). A psychomotor stimulant theory of addiction. Psychological Review, 94, 469-492.
49. Woolverton, W. L., Cervo, L., & Johanson, C. E. (1984). Effects of repeated methamphetamine administration on methamphetamine self-administration in rhesus monkeys. Pharmacology Biochemistry and Behavior, 21, 737-741.